Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Empatica is an affective computing company focused on human data analytics.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Click Therapeutics develops software as a medical treatment prescription platform designed to deliver digital treatments for patients.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Sanofi Ventures has invested in 69 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi Ventures's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Therapeutics, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Dice Therapeutics received $345.0M in a Post-IPO Equity round. Sanofi Ventures's total known invested capital is $4.2B.
Sanofi Ventures's average investment size is $61.3M across its portfolio of 69 companies.
Recent Sanofi Ventures portfolio additions include Tisento Therapeutics, Inozyme, Veralox Therapeutics, QurAlis, Avilar Therapeutics. These companies were founded in 2020 or later.